By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fox Chase Cancer Center in Philadelphia said today that it will partner with Life Technologies to develop, use, and evaluate the use of next-generation clinical sequencing technologies for personalized cancer care.

The partnership will be a cornerstone for the planned Cancer Genome Institute at Fox Chase, which aims to combine multidisciplinary resources at the center to evaluate how genomic sequencing of tumors can be used to manage cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.